Yongheng Bai

2.5k total citations · 1 hit paper
74 papers, 1.9k citations indexed

About

Yongheng Bai is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yongheng Bai has authored 74 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 20 papers in Oncology and 16 papers in Immunology. Recurrent topics in Yongheng Bai's work include Pancreatic and Hepatic Oncology Research (10 papers), Hedgehog Signaling Pathway Studies (10 papers) and Cancer-related Molecular Pathways (6 papers). Yongheng Bai is often cited by papers focused on Pancreatic and Hepatic Oncology Research (10 papers), Hedgehog Signaling Pathway Studies (10 papers) and Cancer-related Molecular Pathways (6 papers). Yongheng Bai collaborates with scholars based in China, United States and Sweden. Yongheng Bai's co-authors include Hong Lu, Shijia Wu, Weilong Hong, Bicheng Chen, Yangyang Guo, Cunzao Wu, Xing Zhang, Hengyue Zhu, Qingqing Ruan and Yanyi Xiao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Chemical Engineering Journal.

In The Last Decade

Yongheng Bai

72 papers receiving 1.9k citations

Hit Papers

Nrf2 in cancers: A double‐edged sword 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongheng Bai China 26 990 331 254 254 217 74 1.9k
Ting C. Zhao United States 33 1.9k 1.9× 365 1.1× 352 1.4× 249 1.0× 247 1.1× 106 2.9k
Samy L. Habib United States 24 1.0k 1.0× 282 0.9× 141 0.6× 297 1.2× 111 0.5× 72 1.8k
Jing Xiong China 24 677 0.7× 260 0.8× 130 0.5× 170 0.7× 187 0.9× 92 1.6k
Mohamed S. Abdel‐Bakky Egypt 20 670 0.7× 247 0.7× 271 1.1× 226 0.9× 140 0.6× 67 1.5k
Yuan Qin China 26 1.2k 1.2× 420 1.3× 258 1.0× 595 2.3× 129 0.6× 120 2.2k
Ya Wang China 26 1.2k 1.2× 378 1.1× 246 1.0× 467 1.8× 99 0.5× 89 2.0k
Sung‐Jig Lim South Korea 24 766 0.8× 387 1.2× 222 0.9× 310 1.2× 92 0.4× 69 1.7k
Hongtao Lu China 18 747 0.8× 283 0.9× 375 1.5× 246 1.0× 113 0.5× 65 1.6k
Jun Shi China 21 714 0.7× 295 0.9× 291 1.1× 230 0.9× 95 0.4× 60 2.0k
Chae Hwa Kwon South Korea 26 1.0k 1.0× 452 1.4× 179 0.7× 327 1.3× 323 1.5× 55 1.9k

Countries citing papers authored by Yongheng Bai

Since Specialization
Citations

This map shows the geographic impact of Yongheng Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongheng Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongheng Bai more than expected).

Fields of papers citing papers by Yongheng Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongheng Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongheng Bai. The network helps show where Yongheng Bai may publish in the future.

Co-authorship network of co-authors of Yongheng Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Yongheng Bai. A scholar is included among the top collaborators of Yongheng Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongheng Bai. Yongheng Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Fan, et al.. (2025). Fraxetin attenuates DNA damage and inflammation in cisplatin-induced nephrotoxicity via FoxO1 activation. International Immunopharmacology. 147. 114010–114010. 1 indexed citations
2.
Zheng, Fan, Boyang Liu, Dongming Su, et al.. (2025). Network Pharmacology and Molecular Docking Elucidate the Mechanism of Phillyrin in Colorectal Cancer. Food Science & Nutrition. 13(10). e71069–e71069.
3.
Han, Hui, Yuanyuan Gao, Hongjie Xu, et al.. (2024). Nrf2 inhibits M1 macrophage polarization to ameliorate renal ischemia–reperfusion injury through antagonizing NF-κB signaling. International Immunopharmacology. 143(Pt 1). 113310–113310. 3 indexed citations
4.
Wang, Jilong, Yiran Wang, Kerui Wu, et al.. (2024). Nano-enabled regulation of DNA damage in tumor cells to enhance neoantigen-based pancreatic cancer immunotherapy. Biomaterials. 311. 122710–122710. 8 indexed citations
5.
Shentu, Yangping, Shuqing Ma, Simin Ye, et al.. (2024). Interleukin‐6 induces cognitive impairment via toll‐like receptor 4 (TLR4)‐mediated neuroinflammation and neurodegeneration in mice with chronic kidney disease. SHILAP Revista de lepidopterología. 2(3). 203–215. 2 indexed citations
6.
Zheng, Fan, et al.. (2024). Investigating the impact of inflammatory response-related genes on renal fibrosis diagnosis: a machine learning-based study with experimental validation. Journal of Biomolecular Structure and Dynamics. 43(15). 8295–8307. 2 indexed citations
7.
Chen, Jiawei, et al.. (2024). Inhibition of aquaporin-9 ameliorates severe acute pancreatitis and associated lung injury by NLRP3 and Nrf2/HO-1 pathways. International Immunopharmacology. 137. 112450–112450. 7 indexed citations
8.
Liu, Xueting, Ji Zhang, Yan Liang, et al.. (2024). tiRNA‐Gly‐GCC‐002 promotes epithelial‐mesenchymal transition and fibrosis in lupus nephritis via FKBP5‐mediated activation of Smad. British Journal of Pharmacology. 182(3). 616–632. 2 indexed citations
9.
Yang, Xuejia, Fan Zheng, Yin Zhang, et al.. (2024). S100A2 activation promotes interstitial fibrosis in kidneys by FoxO1-mediated epithelial-mesenchymal transition. Cell Biology and Toxicology. 40(1). 86–86. 1 indexed citations
10.
Guo, Yangyang, et al.. (2023). Establishment and validation of a ubiquitination-related gene signature associated with prognosis in pancreatic duct adenocarcinoma. Frontiers in Immunology. 14. 1171811–1171811. 6 indexed citations
11.
Zhang, Ji, Bo Chen, Duo Li, et al.. (2023). Role of crescents for lupus nephritis in clinical, pathological and prognosis: a single-center retrospective cohort study. European journal of medical research. 28(1). 60–60. 4 indexed citations
12.
Lin, Feihong, Li‐Chen Chen, Weikang Chen, et al.. (2022). Lipoxin A4 regulates M1/M2 macrophage polarization via FPR2–IRF pathway. Inflammopharmacology. 30(2). 487–498. 36 indexed citations
13.
Shentu, Yangping, Yuyang Li, Shicheng Xie, et al.. (2021). Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling. International Immunopharmacology. 93. 107374–107374. 38 indexed citations
14.
Liang, Yan, Ji Zhang, Bo Chen, et al.. (2021). Dysregulation of tRNA-derived small RNAs and their potential roles in lupus nephritis. Lupus. 30(14). 2248–2255. 8 indexed citations
15.
Ma, Shumei, Lin Liu, Yi Liu, et al.. (2021). Iron-Dependent Autophagic Cell Death Induced by Radiation in MDA-MB-231 Breast Cancer Cells. Frontiers in Cell and Developmental Biology. 9. 723801–723801. 29 indexed citations
16.
Wu, Shijia, Hong Lu, & Yongheng Bai. (2019). Nrf2 in cancers: A double‐edged sword. Cancer Medicine. 8(5). 2252–2267. 352 indexed citations breakdown →
17.
Zhang, Xing, Hong Lu, Cunzao Wu, et al.. (2019). Resveratrol suppresses the myofibroblastic phenotype and fibrosis formation in kidneys via proliferation‐related signalling pathways. British Journal of Pharmacology. 176(24). 4745–4759. 47 indexed citations
18.
Lin, Chengcheng, Hong Lu, Lianfeng Wu, et al.. (2016). [The role of sub-transform of macrophages in renal ischemia/reperfusion injury in rats].. PubMed. 32(4). 338–342. 1 indexed citations
19.
Bai, Yongheng, Bicheng Chen, Weilong Hong, et al.. (2016). Sedum sarmentosum Bunge extract induces apoptosis and inhibits proliferation in pancreatic cancer cells via the hedgehog signaling pathway. Oncology Reports. 35(5). 2775–2784. 24 indexed citations
20.
Chen, Bicheng, et al.. (2011). Glutathione S-transferases T1 null genotype is associated with susceptibility to aristolochic acid nephropathy. International Urology and Nephrology. 44(1). 301–307. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026